Unearthing Nature's Medicines

Lodo Therapeutics Corporation is a drug discovery and development company focused on the creation of novel therapeutics derived from nature that will impact patients around the world. Lodo seeks to work in partnership with global pharmaceutical companies and world leading non-governmental organizations (NGO’s) to tackle some of the greatest challenges in human health: drug-resistant microbial infections and cancers.

Lodo Therapeutics was created to pursue the scientific vision of Dr. Sean Brady at Rockefeller University. Lodo Therapeutics identifies and produces bioactive natural products directly from the microbial DNA sequence information contained in soil. Lodo believes that the potential cures for a number of deadly and/or debilitating diseases literally lie at our feet. Information encoded in bacterial genomes, not experimental serendipity, drives our discovery of new medicines. Not constrained by traditional culture-based approaches to natural products drug discovery, Lodo Therapeutics has unlocked a vast trove of overlooked compounds evolutionarily selected for processes essential for life.

Lodo Therapeutics, an Accelerator Corporation-backed entity, is headquartered in New York City. The company’s lab and offices are located in the Alexandria Center for Life Science, New York City’s first and only premier life science park.

Our Backers

Our Team

The initial management of Lodo Therapeutics will be provided by Accelerator’s core management team of talented professionals with deep investment, operational and scientific expertise. For more information visit: Accelerator Corporation – Senior Leadership

David Pompliano

Chief Scientific Officer, Co-Founder

Sean Brady

Co-Founder

Zach Charlop-Powers

Scientist

Brad Hover

Associate Director, Synthetic Biology

Micah Katz

Research Associate

Sang Ho Lee

Senior Scientist

Our Board

Barbara Dalton, Ph.D.

Pfizer Ventures

Johnston Erwin

Eli Lilly and Company

Steve Gillis, Ph.D.

ARCH Venture Partners

Thong Le

Accelerator Corporation

Joel S. Marcus, J.D., C.P.A.

Alexandria Real Estate Equities, Inc.

James P. Sullivan, Ph.D

AbbVie

Misti Ushio, Ph.D.

Harris & Harris Group, Inc.

Asish Xavier, Ph.D.

JJI-JJDC

Career Opportunities

Join the Team

We're looking for good people

Current Openings

Scientist, Natural Product Chemist

Lab Technician, Microbiology/Molecular Biology



Please send your resume to:
Lodo Therapeutics Corporation
Attn: Human Resources
430 E 29th St, Suite 845
New York, NY 10016
careers@lodotherapeutics.com

News

Press Releases

January 18, 2016 Accelerator Corporation Launches Lodo Theraepeutics with $17 Million Series A to Develop Therapies Derived From Natural Products [link]

In The News

October 31, 2016 C&EN’s 10 Start-ups to watch [www.cen.ACS.org]
January 18, 2016 Lodo loads up series A with $17m [www.globaluniversityventuring.com]
January 18, 2016 Lodo Therapeutics completes venture financing [www.biocentury.com]
January 12, 2016 Accelerator debuts Lodo [www.biocentury.com]
January 11, 2016 Accelerator, Gates Team Up in NY to Put $17M Into Rockefeller Startup [www.xconomy.com]
January 11, 2016 Accelerator’s second NYC biotech startup sets out with $17M and Gates-backed science [www.fiercebiotech.com]
January 11, 2016 New York gets Biotech Boost [www.cen.acs.org]
January 11, 2016 Nice slice of ‘mud’ pie as Accelerator launches Lodo with $17M series A [www.bioworld.com]
January 11, 2016 Gates-backed NYC startup plumbs soil bacteria for tuberculosis therapy [www.medcitynews.com]
January 11, 2016 Life science investment group Accelerator Corp. backs two New York startups [www.geekwire.com]
January 11, 2016 Seattle-based Accelerator Corp. launches first New York companies with $65M in funding [www.bizjournals.com]
January 11, 2016 Daily funding roundup [www.vator.tv]